Michael Miller1, John D Sorkin2, Laura Mastella3, Aimee Sutherland4, Jeffrey Rhyne5, Patrick Donnelly6, Kathy Simpson7, Andrew P Goldberg2. 1. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA; Division of Cardiology, University of Maryland School of Medicine, Baltimore, MD, USA; University of Maryland School of Medicine, Baltimore, MD, USA; Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, Baltimore, USA. Electronic address: mmiller@medicine.umaryland.edu. 2. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; University of Maryland School of Medicine, Baltimore, MD, USA; Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, Baltimore, USA; Division of Gerontology and Geriatric Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. 3. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; University of Maryland School of Medicine, Baltimore, MD, USA; Division of Gerontology and Geriatric Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. 4. University of Maryland School of Medicine, Baltimore, MD, USA. 5. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Division of Cardiology, University of Maryland School of Medicine, Baltimore, MD, USA. 6. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. 7. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, Baltimore, USA; Division of Gerontology and Geriatric Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract
BACKGROUND: The metabolic syndrome (MetS) is highly prevalent and associated with an increased risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Lifestyle recommendations to treat MetS often include the replacement of saturated fats (SFAs) and monosaccharides with unsaturated fat. However, it is unclear whether metabolic parameters will improve more when the saturated fat in American Heart Association (AHA) diets is replaced with higher concentrations of monounsaturated or polyunsaturated fatty acids (MUFA or PUFA). OBJECTIVE: To test the hypothesis that an AHA diet enriched in MUFA improves lipoprotein lipids, insulin resistance, inflammation, and endothelial function to a greater extent than a diet enriched in PUFA in middle-aged men and women with MetS. METHODS: A prospective, open-label, parallel group design with randomization to a hypocaloric MUFA or PUFA-enriched diet after weight stabilization on an AHA step I diet. Participants consumed 3 MUFA-enriched or PUFA-enriched muffins daily with additional supplementation as required to ensure 25%-50% increases in dietary fat intake from these sources at the expense of SFA and the opposing unsaturated fat. Changes in MetS components were measured at baseline and after 6 months of dietary intervention. RESULTS:Thirty-nine participants (mean age, 60.8 years; 79% African-American, 60% women) with MetS completed the 6-month study. Compared to baseline, assignment to either MUFA (n = 23) or PUFA (n = 16) both were associated with weight loss (MUFA: -2.3 ± 1 kg, P = .06; PUFA: -4.6 ± 2 kg; P = .002), but PUFA was also associated with reductions in triglycerides (TG) (-30 ± 18 mg/dL, P = .02), systolic blood pressure (BP) (-7 ± 3 mm Hg, P = .01), diastolic BP (DBP) (-4 ± 2 mm Hg, P = .01) and improved flow mediated dilation (FMD) (7.1% ± 1.8% vs 13.6% ± 2%, absolute increase; P = .0001). When compared to MUFA treatment, PUFA intervention was associated with reduced TG (P = .04) and DBP (P = .07) as well as increased FMD (P = .04) even after adjustment for changes in weight. There was no effect on total cholesterol, low-density lipoprotein cholesterol, glucose, high-sensitivity C-reactive protein (hs-CRP), or other inflammatory proteins. Overall, 25% (4 of 16) assigned to PUFA and 13% (3 of 23) to MUFA converted to non-MetS status. CONCLUSION: Substitution of SFA with PUFA in patients with MetS is associated with greater reductions in TG and improvement in endothelial function than MUFA that is independent of weight loss. These preliminary findings raise the possibility that PUFA may be the unsaturated fat of choice to reduce cardiometabolic risk in patients with MetS.
RCT Entities:
BACKGROUND: The metabolic syndrome (MetS) is highly prevalent and associated with an increased risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Lifestyle recommendations to treat MetS often include the replacement of saturated fats (SFAs) and monosaccharides with unsaturated fat. However, it is unclear whether metabolic parameters will improve more when the saturated fat in American Heart Association (AHA) diets is replaced with higher concentrations of monounsaturated or polyunsaturated fatty acids (MUFA or PUFA). OBJECTIVE: To test the hypothesis that an AHA diet enriched in MUFA improves lipoprotein lipids, insulin resistance, inflammation, and endothelial function to a greater extent than a diet enriched in PUFA in middle-aged men and women with MetS. METHODS: A prospective, open-label, parallel group design with randomization to a hypocaloric MUFA or PUFA-enriched diet after weight stabilization on an AHA step I diet. Participants consumed 3 MUFA-enriched or PUFA-enriched muffins daily with additional supplementation as required to ensure 25%-50% increases in dietary fat intake from these sources at the expense of SFA and the opposing unsaturated fat. Changes in MetS components were measured at baseline and after 6 months of dietary intervention. RESULTS: Thirty-nine participants (mean age, 60.8 years; 79% African-American, 60% women) with MetS completed the 6-month study. Compared to baseline, assignment to either MUFA (n = 23) or PUFA (n = 16) both were associated with weight loss (MUFA: -2.3 ± 1 kg, P = .06; PUFA: -4.6 ± 2 kg; P = .002), but PUFA was also associated with reductions in triglycerides (TG) (-30 ± 18 mg/dL, P = .02), systolic blood pressure (BP) (-7 ± 3 mm Hg, P = .01), diastolic BP (DBP) (-4 ± 2 mm Hg, P = .01) and improved flow mediated dilation (FMD) (7.1% ± 1.8% vs 13.6% ± 2%, absolute increase; P = .0001). When compared to MUFA treatment, PUFA intervention was associated with reduced TG (P = .04) and DBP (P = .07) as well as increased FMD (P = .04) even after adjustment for changes in weight. There was no effect on total cholesterol, low-density lipoprotein cholesterol, glucose, high-sensitivity C-reactive protein (hs-CRP), or other inflammatory proteins. Overall, 25% (4 of 16) assigned to PUFA and 13% (3 of 23) to MUFA converted to non-MetS status. CONCLUSION: Substitution of SFA with PUFA in patients with MetS is associated with greater reductions in TG and improvement in endothelial function than MUFA that is independent of weight loss. These preliminary findings raise the possibility that PUFA may be the unsaturated fat of choice to reduce cardiometabolic risk in patients with MetS.
Authors: A Minniti; L Bissoli; V Di Francesco; F Fantin; R Mandragona; M Olivieri; G Fontana; C Rinaldi; O Bosello; M Zamboni Journal: Eat Weight Disord Date: 2007-12 Impact factor: 4.652
Authors: Marcia C de Oliveira Otto; Dariush Mozaffarian; Daan Kromhout; Alain G Bertoni; Christopher T Sibley; David R Jacobs; Jennifer A Nettleton Journal: Am J Clin Nutr Date: 2012-07-03 Impact factor: 7.045
Authors: Ruth D Smith; Colette N M Kelly; Barbara A Fielding; David Hauton; K D Renuka R Silva; Margaretha C Nydahl; George J Miller; Christine M Williams Journal: Br J Nutr Date: 2003-09 Impact factor: 3.718
Authors: F B Hu; M J Stampfer; J E Manson; E Rimm; G A Colditz; B A Rosner; C H Hennekens; W C Willett Journal: N Engl J Med Date: 1997-11-20 Impact factor: 91.245
Authors: Michael Miller; Valerie Beach; John D Sorkin; Charles Mangano; Christine Dobmeier; Danica Novacic; Jeffrey Rhyne; Robert A Vogel Journal: J Am Diet Assoc Date: 2009-04
Authors: A Keys; A Menotti; M J Karvonen; C Aravanis; H Blackburn; R Buzina; B S Djordjevic; A S Dontas; F Fidanza; M H Keys Journal: Am J Epidemiol Date: 1986-12 Impact factor: 4.897
Authors: Caroline C Duwaerts; Amin M Amin; Kevin Siao; Chris Her; Mark Fitch; Carine Beysen; Scott M Turner; Amanda Goodsell; Jody L Baron; James P Grenert; Soo-Jin Cho; Jacquelyn J Maher Journal: Cell Mol Gastroenterol Hepatol Date: 2017-04-22
Authors: Małgorzata Moszak; Agnieszka Zawada; Aldona Juchacz; Marian Grzymisławski; Paweł Bogdański Journal: Lipids Health Dis Date: 2020-06-20 Impact factor: 3.876
Authors: Alicia Julibert; Maria Del Mar Bibiloni; Cristina Bouzas; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Dolores Corella; Maria Dolors Zomeño; Dora Romaguera; Jesús Vioque; Ángel M Alonso-Gómez; Julia Wärnberg; J Alfredo Martínez; Luís Serra-Majem; Ramon Estruch; Francisco J Tinahones; José Lapetra; Xavier Pintó; José Lopez-Miranda; Laura García-Molina; José Juan Gaforio; Pilar Matía-Martín; Lidia Daimiel; Vicente Martín-Sánchez; Josep Vidal; Clotilde Vázquez; Emili Ros; Estefanía Toledo; Nerea Becerra-Tomás; Olga Pórtoles; Karla A Pérez-Vega; Miquel Fiol; Laura Torres-Collado; Lucas Tojal-Sierra; Rosa Carabaño-Moral; Itziar Abete; Almudena Sanchez-Villegas; Rosa Casas; María Rosa Bernal-López; José Manuel Santos-Lozano; Ana Galera; Lucía Ugarriza; Miguel Ruiz-Canela; Nancy Babio; Oscar Coltell; Helmut Schröder; Jadwiga Konieczna; Domingo Orozco-Beltrán; Carolina Sorto-Sánchez; Sonia Eguaras; Laura Barrubés; Montserrat Fitó; Josep A Tur Journal: Nutrients Date: 2019-06-29 Impact factor: 5.717
Authors: Enrique Albert Pérez; Marina Poveda González; Rosa María Martínez-Espinosa; Mariola D Molina Vila; Manuel Reig García-Galbis Journal: Int J Environ Res Public Health Date: 2019-09-18 Impact factor: 3.390
Authors: Alyssa M Tindall; Kristina S Petersen; Ann C Skulas-Ray; Chesney K Richter; David N Proctor; Penny M Kris-Etherton Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501
Authors: Lívia Martins Costa E Silva; Maria Luisa Pereira de Melo; Fernando Vinicius Faro Reis; Marta Chagas Monteiro; Savio Monteiro Dos Santos; Bruno Alexandre Quadros Gomes; Luiza Helena Meller da Silva Journal: Nutrients Date: 2019-12-23 Impact factor: 5.717